RECRUITING

Identification of Biomarkers for Patients with Vascular Anomalies

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.

Official Title

Identification of Biomarkers for Patients with Vascular Anomalies

Quick Facts

Study Start:2015-04
Study Completion:2050-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03001180

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:1 Day
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Any patient having labs drawn as standard of care will have blood drawn for the study if consented/ assented.
  2. * All patients who are undergoing a surgical procedure or sclerotherapy are currently consented for participation in the tissue bank.
  1. * N/A

Contacts and Locations

Study Contact

Timothy LeCras, PhD
CONTACT
5138034862
hvmcresearch@cchmc.org

Principal Investigator

Timothy LeCras, PhD
PRINCIPAL_INVESTIGATOR
Children's Hospital Medical Center, Cincinnati

Study Locations (Sites)

Boston Children's Hospital
Boston, Massachusetts, 02115
United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229
United States

Collaborators and Investigators

Sponsor: Children's Hospital Medical Center, Cincinnati

  • Timothy LeCras, PhD, PRINCIPAL_INVESTIGATOR, Children's Hospital Medical Center, Cincinnati

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-04
Study Completion Date2050-12

Study Record Updates

Study Start Date2015-04
Study Completion Date2050-12

Terms related to this study

Keywords Provided by Researchers

  • Generalized Lymphatic Anomaly
  • Vascular Anomaly
  • Kaposiform Hemangioendothelioma
  • Kaposiform Lymphangiomatosis
  • Vascular Endothelial Growth Factor
  • Biomarkers
  • GLA
  • KLA
  • KHE
  • GSD

Additional Relevant MeSH Terms

  • Vascular Anomaly
  • Generalized Lymphatic Anomaly
  • Kaposiform Hemangioendothelioma
  • Kaposiform Lymphangiomatosis
  • Gorham-Stout Disease
  • Klippel Trenaunay Syndrome
  • Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi